trial

A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia

NCTId NCT05039489
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 200 (actual)
Sponsored by Central South University
Primary completion 2023-10-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
200 (actual)
Study type
Interventional
Allocation
Randomized
Model
Sequential
Masking
None
Start
2021-09-09
Primary completion
2023-10-31
Eligibility
ALL · 18 Years · 45 Years

Interventions & indications

Drugs
Antipsychotic drugscTBS（the left temporoparietal cortex as the stimulation target）cTBS （the left cerebellum Crus II as the stimulation target）

Sponsors

Central South UniversityLead Sponsor

Investigators

1
Wenbin GuoPrincipal Investigator

Sites

1 total
Changsha, China

Facts & assertions

4 sourced
Enrollment
200
Phase
NA
Primary Completion Date
2023-10-31
Status
COMPLETED
relationships
The graph out of here
drug
Antipsychotic drugs
drug
cTBS（the left temporoparietal cortex as the stimulation target）
drug
cTBS （the left cerebellum Crus II as the stimulation target）
drug
lead_sponsor
Central South University
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Wenbin Guo
person